mutations given The point that, as explained under, CLL therapy is based to the presence or absence of such mutations. The current consensus is usually that, aside from clonal mutations, subclonal mutations having a variant allelic frequency starting from 5 to 10% (and so beneath the threshold of detection by conventional molecular procedures) coul